- €67.16m
- €83.66m
- €111.96m
- 47
- 44
- 76
- 57
Annual income statement for Alkemy SPA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 73.9 | 94 | 105 | 115 | 112 |
Cost of Revenue | |||||
Gross Profit | 34.8 | 48.4 | 57.2 | 64.2 | 60.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 70.8 | 87.3 | 97.3 | 108 | 125 |
Operating Profit | 3.15 | 6.62 | 7.51 | 6.89 | -12.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.54 | 5.77 | 7.1 | 4.84 | -15 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.82 | 4.27 | 5.61 | 3.54 | -14.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.79 | 4.26 | 5.58 | 3.46 | -14.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.79 | 4.26 | 5.58 | 3.46 | -14.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.392 | 0.987 | 1.17 | 0.836 | -0.853 |
Dividends per Share |